+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new class of HIV-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere



A new class of HIV-1 protease inhibitor: the crystallographic structure, inhibition and chemical synthesis of an aminimide peptide isostere



Bioorganic and Medicinal Chemistry 4(9): 1545-1558



The essential role of HIV-1 protease (HIV-1 PR) in the viral life cycle makes it an attractive target for the development of substrate-based inhibitors that may find efficacy as anti-AIDS drugs. However, resistance has arisen to potent peptidomimetic drugs necessitating the further development of novel chemical backbones for diversity based chemistry focused on probing the active site for inhibitor interactions and binding modes that evade protease resistance. AQ148 is a potent inhibitor of HIV-1 PR and represents a new class of transition state analogues incorporating an aminimide peptide isostere. A 3-D crystallographic structure of AQ148, a tetrapeptide isostere, has been determined in complex with its target HIV-1 PR to a resolution of 2.5 A and used to evaluate the specific structural determinants of AQ148 potency and to correlate structure-activity relationships within the class of related compounds. AQ148 is a competitive inhibitor of HIV-1 PR with a Ki value of 137 nM. Twenty-nine derivatives have been synthesized and chemical modifications have been made at the P1, P2, P1', and P2' sites. The atomic resolution structure of AQ148 bound to HIV-1 PR reveals both an inhibitor binding mode that closely resembles that of other peptidomimetic inhibitors and specific protein/inhibitor interactions that correlate with structure-activity relationships. The structure provides the basis for the design, synthesis and evaluation of the next generation of hydroxyethyl aminimide inhibitors. The aminimide peptide isostere is a scaffold with favorable biological properties well suited to both the combinatorial methods of peptidomimesis and the rational design of potent and specific substrate-based analogues.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045079385

Download citation: RISBibTeXText

PMID: 8894111

DOI: 10.1016/0968-0896(96)00147-2


Related references

Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P-1'-P-2' amide bond isostere. Journal of Medicinal Chemistry 37(19): 3100-3107, 1994

Synthesis of a new hydroxyethylene dipeptide isostere Phe-PSI (CH-2CH(OH))Phe as HIV-1 protease inhibitor. Acta Pharmacologica Sinica 15(1): 33-35, 1994

Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor. Zhongguo Yao Li Xue Bao 15(1): 33-35, 1994

Synthesis and antiviral activity of a novel class of HIV-1 protease inhibitors containing a heterocyclic P-1'-P-2' amide bond isostere. Bioorganic and Medicinal Chemistry Letters 4(20): 2441-2446, 1994

Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease. Bioorganic and Medicinal Chemistry 2(10): 1085-1090, 1994

a-Ketoamide PhePro isostere as a new core structure for the inhibition of HIV protease. Bioorganic & Medicinal Chemistry 2(10): 1085-1090, 1994

Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor. Journal of Medicinal Chemistry 45(7): 1432-1438, March 28, 2002

An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611. Journal of Organic Chemistry 71(14): 5369-5372, 2006

On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution. Acta Crystallographica. Section D, Biological Crystallography 62(Pt 5): 489-497, 2006

Studies on an artificial trypsin inhibitor peptide derived from the mung bean trypsin inhibitor: chemical synthesis, refolding, and crystallographic analysis of its complex with trypsin. Journal of Biochemistry 116(1): 18-25, 1994

On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 angstrom resolution. Acta Crystallographica Section D Biological Crystallography 62(Part 5): 489-497, 2006

Crystal structure of chemically synthesized HIV-1 protease and a ketomethylene isostere inhibitor based on the p2/NC cleavage site. Bioorganic and Medicinal Chemistry Letters 18(16): 4554-4557, 2008

Asymmetric dihydroxylation route to a dipeptide isostere of a protease inhibitor: enantioselective synthesis of the core unit of ritonavir. Chemical Communications 1999(11): 1025-1026, 1999

Reprint of Crystal structure of chemically synthesized HIV-1 protease and a ketomethylene isostere inhibitor based on the p2/NC cleavage site  †. Bioorganic & Medicinal Chemistry Letters 18(22): 6012-6015, 2008

A stereospecific synthesis of a renin inhibitor(BW-175) which incorporates a sulfonemethylene isostere and a dihydroxyethylene isostere. Tetrahedron letters1(11): 1569-1572, 1990